Salud financiera de hoja de balance de Poly Medicure
Salud financiera controles de criterios 6/6
Poly Medicure tiene un patrimonio de accionistas total de ₹13.4B y una deuda total de ₹1.4B, lo que sitúa su ratio deuda-patrimonio en 10.1%. Sus activos y pasivos totales son ₹17.0B y ₹3.6B respectivamente. El BAIT de Poly Medicure es de ₹2.8B, por lo que su ratio de cobertura de intereses es de -38.1. Tiene efectivo e inversiones a corto plazo que ascienden a ₹2.8B.
Información clave
11.8%
Ratio deuda-patrimonio
₹1.74b
Deuda
| Ratio de cobertura de intereses | 25.6x |
| Efectivo | ₹2.86b |
| Patrimonio | ₹14.70b |
| Total pasivo | ₹3.89b |
| Activos totales | ₹18.59b |
Actualizaciones recientes sobre salud financiera
Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25Recent updates
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00
Sep 14After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar
Sep 06Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138
Jul 27Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)
Jul 11Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return
Mar 01I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease
Feb 16Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹8.1B) de POLYMED superan a sus pasivos a corto plazo (₹3.2B).
Pasivo a largo plazo: Los activos a corto plazo de POLYMED (₹8.1B) superan a sus pasivos a largo plazo (₹381.9M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: POLYMED tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de POLYMED ha pasado de 41.5% a 10.1% en los últimos 5 años.
Cobertura de la deuda: La deuda de POLYMED está bien cubierta por el flujo de caja operativo (176.9%).
Cobertura de intereses: Los pagos de intereses de la deuda de POLYMED están bien cubiertos por el BAIT (31.2x cobertura).